SLS

Sellas Life Sciences Group Stock Analysis

AI Rating

Good
  • Quality1/10
  • Growth↑ 6/10
  • Value↑ 6/10
Sellas Life Sciences Group sales and earnings growth
SLS Growth
Good
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 50.00%
  • FCF Y/Y↑ 19.81%
Sellas Life Sciences Group gross and profit margin trends
SLS Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↑ 750.67%
Sellas Life Sciences Group net debt vs free cash flow
SLS Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Sellas Life Sciences Group stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗